For Immediate Release:
Thursday, November 14th, 2019
María R. González Albuixech
Director of Communications, Health Care For All
Press Statement from Amy Rosenthal, Executive Director of Health Care For All, Regarding the Legislation Approved Today by the State Senate to Address the High Cost of Prescription Drugs:
"Heath Care For All applauds the Senate for taking bold action by unanimously passing the Pharmaceutical Access Cost and Transparency (PACT) Act to tackle the skyrocketing cost of prescription drugs for individuals and families with private insurance. The PACT Act includes both transparency and accountability provisions, which are critical to lowering costs for the health care system and consumers. The strong framework includes reporting to understand drug pricing, disclosing the proposed value of certain drugs if manufacturers don't take meaningful steps to lower costs, and providing information on the lowest cost and most effective medications. This language reflects the priorities of a broad coalition of seniors, doctors, insurers, faith based groups, unions and consumers that have advocated for bringing down the high cost of prescription drugs.
"Health Care For All was especially pleased to see the accountability provisions in the bill strengthened during today's debate by the adoption of an amendment from Senate President Emerita Chandler to give prescription drug manufacturers the right incentives to come to the table to lower costs.
"We thank Chair Friedman, Senate President Spilka and Chair Rodrigues for their tireless leadership and dedication. We look forward to working with the House of Representatives as they also consider legislative solutions to tackle this critical issue. We are encouraged to see the Governor, Senate and House prioritizing the issue of prescription drug costs, and are excited to work with them to pass legislation that will help consumers across the state afford the medications they need."